Skip to main content
Signal8

Babarczy Julian Michael

SEC insider (Form 3/4/5 filer). CIK 0002127744. Director at ALTERITY THERAPEUTICS LTD (ATHE). 1 reported Form 4/5 transaction since Sep 2024; latest on Jun 15, 2026. Located in MELBOURNE.

Companies Babarczy Julian Michael has filed insider reports for

  • ALTERITY THERAPEUTICS LTD (ATHE): Director
Babarczy Julian Michael profile photo

Babarczy Julian Michael

CIK: 0002127744

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)1 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

ALTERITY THERAPEUTICS LTD logo
ATHE

ALTERITY THERAPEUTICS LTD

Director

Discretionary Trading P&L

Holdings

Transaction History (1 total)

  • ALTERITY THERAPEUTICS LTD logo
    ATHE

    ALTERITY THERAPEUTICS LTD

    Jun 15, 2026
    Award

    Unlisted option exp 15 Jun 2031

    Indirect
    2M shares-

1-1 of 1